ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia

Kong, Junying; Deng, Ying*哈尔滨医科大学; y
Revista Portuguesa de Cardiologia2022-10DOI: 10.1016/j.repc.2021.12.011
1被引14阅读
引用收藏
分享

摘要

Objectives: Hyperhomocysteinemia (HHcy) can induce vascular inflammatory and oxidative damage and accelerate intimal hyperplasia. This study investigated the protective effect of pirfenidone (PFD) on the recovery process of injured endothelial arteries during HHcy. Materials and methods: Thirty rabbits were randomly separated into three groups: A control group (n=10, standard rabbit chow), a model group (n=10, control diet plus 30 g methion-ine/kg food), and a PFD group (n=10, model diet plus oral administration of 90 mg/day of PFD). After 14 weeks of arterial injury, histopathological changes were determined. Plasma homocys-teine (Hcy) concentrations, lipid profiles and oxidant and antioxidant status were evaluated. Macrophage infiltration was assessed using immunohistochemical staining. Results: PFD supplementation decreased macrophage infiltration of iliac artery significantly without changes in blood lipids and Hcy concentrations. Compared with the model group, PFD restored superoxide dismutase and glutathione peroxidase activities and reduced malon-dialdehyde and reactive oxygen species levels. A high-methionine diet significantly increased neointimal area and the ratio between neointimal and media area. Systemic administration of PFD inhibited neointimal formation. Conclusions: PFD can partly alleviate intimal hyperplasia by inhibiting inflammatory and oxida-tive stress response induced by HHcy during endothelial injury. It may be a potential therapeutic agent for the prevention and treatment of endothelial injury-associated diseases such as atherosclerosis.

学科与关键词

关键词
Inflammatory responseOxidative stressVascular damageNeointimal hyperplasiaAtherosclerosisHyperhomocysteinemia
相关
加载中…
  • Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder
    Zhang, Shan; Lv, Ying; Luo, Xing; Weng, Xiuzhu; Qi, Jinyu; Bai, Xiaoxuan; Zhao, Chen; Zeng, Ming; Bao, Xiaoyi; Dai, Xinyu; Zhang, Ying; Chen, Yuwu; Liu, Minghao; Hu, Sining; Li, Ji*; Jia, Haibo*Molecular Medicine, 2023, 29(1): 73.被引 3
  • Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis
    Yang, Shan; Zhang, Renzi; Deng, Wenzhen; Chang, Shichuan; Li, Yang*; Li, Sheng*Inflammation Research, 2023, 72(9): 1773-1787.
  • Metformin attenuates carotid neointimal hyperplasia by modulating the vascular smooth muscle cell phenotype transformation through upregulation of TET2, Nur77 and calponin
    Lin, Hao; Cheng, Shuo; Yuan, Zhichao; Yan, Zhiqiang; Zhang, Jifa*Archives of Biological Sciences, 2021, 73(1): 135-144.
查看全部 →

发表信息

论文状态
公开发表
期刊
Revista Portuguesa de Cardiologia
发表日期
2022-10
卷期
第 41 卷, 第 10 期
页码
813-819
DOI
10.1016/j.repc.2021.12.011
语言
MULTI-LANGUAGE
期刊等级
4区
成果收录
SCIE

作者

  • K

    Kong, Junying (第一作者)

    2 · harbin med univ

  • D

    Deng, Ying (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417